We are live on
!
Find out more
SC
Samlyn Capital Portfolio holdings
AUM
$5.86B
1-Year Est. Return
36.3%
This Fund
S&P 500
This Quarter
Est. Return
-4.6%
1 Year Est. Return
+36.3%
3 Year Est. Return
+115.4%
5 Year Est. Return
+175.71%
10 Year Est. Return
+881.8%
AUM
$6.75B
AUM Growth
+$130M
(+2%)
Cap. Flow
+$630M
Cap. Flow
% of AUM
9.32%
Top 10 Holdings %
Top 10 Hldgs %
40.73%
Holding
114
New
21
Increased
30
Reduced
29
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$277M |
| 2 |
Burlington
BURL
|
+$175M |
| 3 |
PRMB
Primo Brands
PRMB
|
+$122M |
| 4 |
TSMC
TSM
|
+$120M |
| 5 |
RB Global
RBA
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$193M |
| 2 |
American Tower
AMT
|
+$134M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$113M |
| 4 |
Starbucks
SBUX
|
+$111M |
| 5 |
Truist Financial
TFC
|
+$88.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 29.03% |
| 2 | Consumer Discretionary | 28.07% |
| 3 | Technology | 12.42% |
| 4 | Industrials | 6.02% |
| 5 | Consumer Staples | 4.49% |
Similar funds
LIP
JSSH
CIC
BSL
MWM
TCM
VAM
WAM
Samlyn Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Samlyn Capital held 114 positions worth $6.75B, up 2% from $6.62B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Samlyn Capital deployed $630M of net new capital in Q1 2025, opening 21 new positions and adding to 30 existing holdings. Its largest new stake was JPMorgan Chase: 1,085,244 shares worth $266M.
By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Truist Financial, an estimated $88.4M trimmed.
- Samlyn Capital's largest Q1 2025 buy was JPMorgan Chase: 1,085,244 shares worth $266M.
- Samlyn Capital added most to Primo Brands in Q1 2025, an estimated $122M increase.
- Samlyn Capital's biggest Q1 2025 reduction was Truist Financial, cutting an estimated $88.4M.
- Samlyn Capital fully exited Pfizer in Q1 2025, selling an estimated $193M.
- Samlyn Capital's ten largest holdings make up 41% of its $6.75B portfolio in Q1 2025.
- Samlyn Capital opened 21 new positions and closed 32 in Q1 2025.
- Samlyn Capital's portfolio value rose 2% quarter-over-quarter to $6.75B.
Based on Samlyn Capital's 13F filing for Q1 2025, filed 15 May 2025.